|
1. |
Regulation of the Growth Arrest and DNA Damage-Inducible Gene 45 (GADD45) by Peroxisome Proliferator-Activated Receptor &ggr; in Vascular Smooth Muscle Cells |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 38-47
Dennis Bruemmer,
Fen Yin,
Joey Liu,
Joel Berger,
Toshiyuki Sakai,
Florian Blaschke,
Eckart Fleck,
Andre Van Herle,
Barry Forman,
Ronald Law,
Preview
|
PDF (297KB)
|
|
摘要:
Abstract—Peroxisome proliferator-activated receptor (PPAR) &ggr; is activated by thiazolidinediones (TZDs), widely used as insulin-sensitizing agents for the treatment of type 2 diabetes. TZDs have been shown to induce apoptosis in a variety of mammalian cells. In vascular smooth muscle cells (VSMCs), proliferation and apoptosis may be competing processes during the formation of restenotic and atherosclerotic lesions. The precise molecular mechanisms by which TZDs induce apoptosis in VSMCs, however, remain unclear. In the present study, we demonstrate that the TZDs rosiglitazone (RSG), troglitazone (TRO), and a novel non-TZD partial PPAR&ggr; agonist (nTZDpa) induce caspase-mediated apoptosis of human coronary VSMCs. Induction of VSMC apoptosis correlated closely with an upregulation of growth arrest and DNA damage-inducible gene 45 (GADD45) mRNA expression and transcription, a well-recognized modulator of cell cycle arrest and apoptosis. Using adenoviral-mediated overexpression of a constitutively active PPAR&ggr; mutant and the irreversible PPAR&ggr; antagonist GW9662, we provide evidence that PPAR&ggr; ligands induce caspase-mediated apoptosis and GADD45 expression through a receptor-dependent pathway. Deletion analysis of the GADD45 promoter revealed that a 153-bp region between −234 and −81 bp proximal to the transcription start site, containing an Oct-1 element, was crucial for the PPAR&ggr; ligand–mediated induction of the GADD45 promoter. PPAR&ggr; activation induced Oct-1 protein expression and DNA binding and stimulated activity of a reporter plasmid driven by multiple Oct-1 elements. These findings suggest that activation of PPAR&ggr; can lead to apoptosis and growth arrest in VSMCs, at least in part, by inducing Oct-1–mediated transcription of GADD45. The full text of this article is available online at http://www.circresaha.org.
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
2. |
Correction |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 48-48
Preview
|
PDF (6KB)
|
|
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
3. |
Homocysteine, a Proinflammatory and Proatherosclerotic FactorRole of Intracellular Reactive Oxygen Species |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 271-273
Valérie Schini-Kerth,
Preview
|
PDF (36KB)
|
|
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
4. |
T-Type Calcium Current in Sickle Cell DiseaseA Channel to Therapy? |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 274-276
Anthony Varghese,
Edward Weir,
Preview
|
PDF (45KB)
|
|
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
5. |
The Obesity-Associated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 277-279
Venkatesh Rajapurohitam,
Xiaohong Gan,
Lorrie Kirshenbaum,
Morris Karmazyn,
Preview
|
PDF (173KB)
|
|
摘要:
One of the major manifestations of obesity is increased production of the adipocyte-derived 16-kDa peptide leptin, which is also elevated in heart disease, including congestive heart failure. However, whether leptin can directly alter the cardiac phenotype is not known. We therefore studied the effect of leptin as a potential hypertrophic factor in cultured myocytes from 1- to 4-day-old neonatal rat heart ventricles. Using RT-PCR, we demonstrate that these cells express the short-form (OB-Ra) leptin receptor. Twenty-four hours of exposure to leptin (0.31 to 31.3 nmol/L) produces a significantly increased cell surface area that peaked at 0.63 nmol/L. Subsequent experiments were done with 3.1 nmol/L leptin, which significantly increased cell area by 42%, protein synthesis by 32%, and &agr;-skeletal actin and myosin light chain-2 expression by 250% and 300%, respectively. These events occurred in the absence of any increased cell death. Hypertrophy was preceded by rapid activation of the mitogen-activated protein kinase system including p38 and p44/42 as early as 5 minutes after leptin addition, whereas hypertrophy was inhibited by the p38 inhibitor SB203580 but not by the p44/42 inhibitor PD98059. Our results demonstrate a direct hypertrophic effect of leptin and may offer a biological link between hypertrophy and hyperleptinemic conditions such as obesity.
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
6. |
Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 280-291
Sergei Rybalkin,
Chen Yan,
Karin Bornfeldt,
Joseph Beavo,
Preview
|
PDF (313KB)
|
|
摘要:
Abstract—Cyclic GMP (cGMP) made in response to atrial natriuretic peptide (ANP) or nitric oxide (NO) is an important regulator of short-term changes in smooth muscle tone and longer-term responses to chronic drug treatment or proliferative signals. The ability of smooth muscle cells (SMCs) to utilize different combinations of phosphodiesterase (PDE) isozymes allows cGMP to mediate these multiple processes. For example, PDE5 as a major cGMP-hydrolyzing PDE effectively controls the development of smooth muscle relaxation. In order for contraction to occur, PDE5 is activated and cGMP falls. Conversely, blockade of PDE5 activity allows the relaxation cycle to be prolonged and enhanced. A recently shown direct activation of PDE5 by cGMP binding to the GAF A domain suggests that this regulatory site might be a target for new drug development. The calcium surge associated with vasoconstrictor initiated contraction also activates a calcium/calmodulin-dependent PDE (PDE1A). Together, PDE5 and PDE1A lower cGMP sufficiently to allow contraction. Longer term, both PDE5 and PDE1A mRNA are induced by chronic stimulation of guanylyl cyclase. This induction is a major cause of the tolerance that develops to NO-releasing drugs. Finally, high levels of cGMP or cAMP also act as a brake to attenuate the proliferative response of SMCs to many mitogens. After vessel damage, in order for SMC proliferation to occur, the levels of cGMP and cAMP must be decreased. In humans, this decrease is caused in large part by induction of another Ca2+/calmodulin-dependent PDE (PDE1C) that allows the brake to be released and proliferation to start.
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
7. |
Role of the Mitochondrial Permeability Transition in Myocardial Disease |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 292-301
James Weiss,
Paavo Korge,
Henry Honda,
Peipei Ping,
Preview
|
PDF (395KB)
|
|
摘要:
Abstract—Mitochondria play a key role in determining cell fate during exposure to stress. Their role during ischemia/reperfusion is particularly critical because of the conditions that promote both apoptosis by the mitochondrial pathway and necrosis by irreversible damage to mitochondria in association with mitochondrial permeability transition (MPT). MPT is caused by the opening of permeability transition pores in the inner mitochondrial membrane, leading to matrix swelling, outer membrane rupture, release of apoptotic signaling molecules such as cytochromecfrom the intermembrane space, and irreversible injury to the mitochondria. During ischemia (the MPT priming phase), factors such as intracellular Ca2+accumulation, long-chain fatty acid accumulation, and reactive oxygen species progressively increase mitochondrial susceptibility to MPT, increasing the likelihood that MPT will occur on reperfusion (the MPT trigger phase). Because functional cardiac recovery ultimately depends on mitochondrial recovery, cardioprotection by ischemic and pharmacological preconditioning must ultimately involve the prevention of MPT. Investigations into this area are beginning to unravel some of the mechanistic links between cardioprotective signaling and mitochondria.
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
8. |
Betacellulin and Amphiregulin Induce Upregulation of Cyclin D1 and DNA Synthesis Activity Through Differential Signaling Pathways in Vascular Smooth Muscle Cells |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 302-310
Hyoung Shin,
Hyo Lee,
Makoto Nishida,
Mi-Sook Lee,
Ritsu Tamura,
Shizuya Yamashita,
Yuji Matsuzawa,
In-Kyu Lee,
Gou Koh,
Preview
|
PDF (552KB)
|
|
摘要:
Abstract—Activation of EGF receptors is closely involved in vascular proliferative diseases. The signaling mechanisms of EGF ligands, including betacellulin (BTC) and amphiregulin (AR), are poorly understood. We examined how BTC and AR induced DNA synthesis activity in primary cultures of human thoracic aortic smooth muscle cells (HTASMCs). BTC induced phosphorylation of all four EGF receptors present on HTASMCs: ErbB1, ErbB2, ErbB3, and ErbB4. BTC rapidly induced the phosphorylation of Akt, GSK3&agr;/&bgr;, and two FoxO factors, FKHR and AFX, in a dose- and time-dependent manner. BTC increased nuclear &bgr;-catenin accumulation. BTC increased cyclin D1 mRNA, cyclin D1 protein, and DNA synthesis activity. Pretreatment with the phosphatidylinositol 3′-kinase (PI 3′-kinase) inhibitor wortmannin suppressed BTC-induced cyclin D1 mRNA and protein and DNA synthesis activity. In contrast, AR, a specific ErbB1 ligand, induced sustained ERK1/2 and Elk1 phosphorylation, increased cyclin D1 mRNA and protein, and increased DNA synthesis activity. AR did not produce any changes in Akt phosphorylation. Pretreatment with PD98059 suppressed AR-induced cyclin D1 mRNA and protein. Thus, the PI 3′-kinase/Akt/GSK/FoxO/&bgr;-catenin pathway could be the major signaling cascade for BTC-induced upregulation of cyclin D1 protein, whereas a sustained ERK/Elk1 activation could be the major signaling cascade for AR-induced upregulation of cyclin D1 protein in HTASMCs. Moreover, immunohistochemical staining revealed that that BTC, ErbB1, and ErbB4 are upregulated in the plaques of human atherosclerotic coronary arteries. Taken together, BTC and AR could be potent growth factors in proliferative vascular diseases.
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
9. |
Homocysteine Mediated Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Monocytes |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 311-320
Xiaokun Zeng,
Jing Dai,
Daniel Remick,
Xian Wang,
Preview
|
PDF (221KB)
|
|
摘要:
Abstract—Homocysteine (Hcy) is an independent risk factor for cardiovascular disease. Monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) are major chemokines for leukocyte trafficking and have been identified in atheromatous plaques. MCP-1 and IL-8 have been found to express mainly by macrophages in human lesion. We undertook this study to determine whether Hcy could induce the secretion of chemokines from human monocytes and, if so, to explore the mediating mechanism. We found that clinically relevant levels of Hcy (10 to 1000 &mgr;mol/L) increased the protein secretion and mRNA expression as well as activity of MCP-1 and IL-8 in cultured primary human monocytes. These effects of Hcy were primarily mediated by reactive oxygen species (ROS) through NAD(P)H oxidase, because Hcy could upregulate the production of ROS and the inhibitors of protein kinase C, calmodulin, free radical scavengers, or NAD(P)H oxidase abolished Hcy-induced ROS production and MCP-1 and IL-8 secretion in these cells. Furthermore, the inhibitors of mitogen-activated protein kinase (p38 and extracellular signal-regulated kinase 1/2) and nuclear factor-&kgr;B or the activator of peroxisome proliferator-activated receptor &ggr; (PPAR&ggr;) significantly decreased Hcy-induced MCP-1 and IL-8 secretion in these cells. These data indicate that pathophysiological levels of Hcy can alter human monocyte function by upregulating MCP-1 and IL-8 expression and secretion via enhanced formation of intracellular ROS originated from NAD(P)H oxidase source via calmodulin or protein kinase C signaling pathways and that Hcy-induced ROS subsequently activates mitogen-activated protein kinase (p38 and ERK1/2) and nuclear factor-&kgr;B in a PPAR&ggr; activator–sensitive manner. Thus, activation of PPAR&ggr; may become a therapeutic target for preventing Hcy-induced proatherogenic effects.
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
10. |
Migration Inhibitory Factor Mediates Angiogenesis via Mitogen-Activated Protein Kinase and Phosphatidylinositol Kinase |
|
Circulation Research: Journal of the American Heart Association,
Volume 93,
Issue 4,
2003,
Page 321-329
M. Amin,
Olga Volpert,
James Woods,
Pawan Kumar,
Lisa Harlow,
Alisa Koch,
Preview
|
PDF (432KB)
|
|
摘要:
Abstract—In this study, we investigated the effects of migration inhibitory factor (rhMIF) on angiogenesis-related signaling cascades and apoptosis in human endothelial cells (ECs). We show that in vitro rhMIF induces migration and tube formation in Matrigel of human dermal microvascular endothelial cells (HMVECs), with potency comparable to that of basic fibroblast growth factor. In vivo, rhMIF induces angiogenesis in Matrigel plugs and in the corneal bioassay. Using panels of relatively specific kinase inhibitors, antisense oligonucleotides, and dominant-negative mutants, we show that mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) are critical for MIF-dependent HMVEC migration, whereas Src and p38 kinases are nonessential. Moreover, we demonstrate that rhMIF induces time-dependent increases in phosphorylation levels of MEK1/2, Erk1/2, and Elk-1, as well as PI3K, and its effector kinase, Akt, in HMVECs. Studies with dominant-negative mutants and antisense oligonucleotides corroborate these effects in HMVECs. Furthermore, we demonstrate that rhMIF-induced angiogenesis in the rat cornea in vivo and in the ex vivo endothelial cell morphogenesis assay is also MAPK- and PI3K-dependent. Our findings support a role for MIF as an angiogenic factor and provide a rationale for the use of MIF as a therapeutic inducer of neovascularization in the development of collateral circulation in coronary artery disease.
ISSN:0009-7330
出版商:OVID
年代:2003
数据来源: OVID
|
|